FDA Approves Two New Medications to Treat Acute Migraine Attacks — Guest Blogger Chicago Headache Center & Research Institute

Moving Forward 2 comments

In the last six weeks two new oral medications have become available for the acute treatment of migraine. Reyvow (lasmitidan) was approved by the Food and Drug Aministration (FDA) October 11, 2019, but it has only recently been made available to prescribe. Ubrelvy (ubrogepant) was approved by FDA December 23, 2019, and is also now […]

FDA Approves Two New Medications to Treat Acute Migraine Attacks — Chicago Headache Center & Research Institute

2 comments

Leave a Reply

Please log in using one of these methods to post your comment:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s